Effect of Lactobacillus gasseri BNR17 on bowel function in Irritable Bowel Syndrome with diarrhea

Effect of Lactobacillus gasseri BNR17 on bowel function in Irritable Bowel Syndrome with diarrhea: a randomized, double-blind, controlled study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000969

Enrollment

Registered

2013-12-31

Start date

2013-12-06

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Consumption of Lactobacillus gasseri BNR17 or placebo for 8 weeks(twice a day)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Voluntarily agree to participate and sign in informed consent form 2) Adults aged 20~55 3) IBS with diarrhea (diagnosed by ROME III critetia)

Exclusion criteria

Exclusion criteria: 1) Consumption of medicine for IBS treatment, probiotic products, antibiotics or antiinflammatory drugs within 4 weeks (28 days) before the first visit 2) Following diseases : ? Liver dysfunction ? Renal dysfunction 3) Any condition that the principal investigator belives may put the subjects at undue risk 4)Pregnant or lactating women, alcoholic, mental patient 5)Hypersensitivity to probiotics

Design outcomes

Primary

Measure	Time frame
questionnaire for bowel function	—

Secondary

Measure	Time frame
colonic transit time test;biomarkers on blood glucose	—

Countries

Korea, Republic of

Contacts

Public ContactSanghee Song

Bundang CHA General Hospital

Outcome results